Nano Terra to Use Surface Functionalizing Technology for Water Treatment

Pentair, Inc. (NYSE: PNR) and Nano Terra, Inc., announced today they are forming a strategic alliance in water treatment. Pentair is a global leader in water movement, treatment, and storage technologies; and Nano Terra is a leading surface engineering and nanotechnology co-development company.

Nano Terra will deploy its technology for functionalizing surfaces through chemistry and structuring to develop new solutions for the treatment of water with improved performance. Nano Terra's technology platform was pioneered by its co-founder, Professor George M. Whitesides of Harvard University. Nano Terra will carry out the research at its labs in Cambridge, Mass. under close collaboration with a Pentair team that will manage field testing of the joint solution.

"New water treatment technologies will be a key element to satisfying the growing global concerns of water scarcity and poor quality. We are committed to innovation and to bringing the most effective technologies to our customers and are delighted to be our industry's first collaborators with Nano Terra," said Dr. Philip M. Rolchigo, vice president of Water Technology, Pentair. "Accessing Nano Terra's unique technology portfolio in a collaborative manner will allow us continued innovation in the sector."

Myer Berlow, CEO of Nano Terra, added, "Pentair has a long history of leading the sector through innovation. We look forward to working with them on critical water management applications, and are proud that Pentair recognizes the value of our surface engineering and nanotechnology expertise."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.